A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006] |
Lendvai, Nikoletta |
|
A Phase IB Study of SGN-75 plus Everolimus in Patients with CD70-Positive Metastatic Renal Cell Cancer
[Protocol 12-263] |
Molina, Ana Maria |
|
A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab
[Protocol 09-093] |
Modi, Shanu |
|
A Phase IB Study of Vismodegib in Patients with Liver Cancer with Varying Degrees of Kidney and Liver Function
[Protocol 12-031] |
Abou-Alfa, Ghassan |
|
A Phase IB/II Study Evaluating Doxorubicin with or without a IMC-3G3 to Treat Advanced Soft-Tissue Sarcoma
[Protocol 10-156] |
Tap, William |
|
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma
[Protocol 10-084] |
Molina, Ana Maria |
|
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104] |
Tap, William |
|
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234] |
O'Reilly, Eileen |
|
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174] |
Gerecitano, John |
|
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170] |
Horwitz, Steven |
|
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056] |
Zelefsky, Michael |
|
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] |
Rimner, Andreas |
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
|
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094] |
Wu, Abraham |
|
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Lymphoma
|
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140] |
Traina, Tiffany |
|
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187] |
Scher, Howard |
- Prostate Cancer
- Rising PSA After Primary Therapy
|
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082] |
Traina, Tiffany |
|
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063] |
Dickler, Maura |
|
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166] |
Janjigian, Yelena |
- Upper Gastrointestinal
- Esophageal Cancer
- Gastric Cancer
|
